In addition, re‐analysis of published CRISPR screens (Wang et al,2015; Wang et al,2017; Phelan et al,2018), indicated selective requirement for endophilin A2 for growth of B‐cell lymphoma lines, particularly Burkitt and GCB diffuse large B‐cell lymphoma types, but not the diffuse large B‐cell ABC type or other hematopoietic lines (Fig EV4D). Here, SH3GL1 is linked to B-cell non-Hodgkin lymphoma.